N@N

SYNERON MEDICAL LTD (NASDAQ:ELOS), Down By 3.52% ($0.44) From $12.500 After BUYINS.NET Report Predicted Weakness After Earnings

^{Published on 2011-06-03 05:21:26 - WOPRAI}
 

June 3, 2011 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Wednesday, May 18th 2011 stating that SYNERON MEDICAL LTD (NASDAQ:ELOS) was expected to be Down After its earnings release. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=elos&id=167560

At the time this story was written, SYNERON MEDICAL LTD (NASDAQ:ELOS) is Down By 3.52% ($0.44) From $12.500 since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

SYNERON MEDICAL LTD (NASDAQ:ELOS) - Syneron Medical Ltd., together with its subsidiaries, engages in the research, development, marketing, and sale of aesthetic medical products worldwide. The company develops products based on its proprietary ELOS technology, which combines conducted radiofrequency energy, an electrical energy; and light or laser-based energy, an optical energy. Its products target a range of non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, and rejuvenation of the skins appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, and invasive products for laser-assisted lipolysis, as well as develops dental laser devices. The company sells its products primarily to physicians and other practitioners, including plastic surgeons, aestheticians, medical spas, dentists, dermatologists, and cosmetic physicians. The company sells its products primarily to physicians and other practitioners, including plastic surgeons, aestheticians, medical spas, dentists, dermatologists, and cosmetic physicians. Syneron Medical Ltd. sells its products through a direct sales force in the United States and Canada, and through distributors in Europe, the Middle East, South Africa, the Asia-Pacific region, and South and Central America. The company was founded in 2000 and is headquartered in Yokneam Illit, Israel.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market-maker surveillance system tracking market makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and all Threshold Security Lists daily for which stocks have naked short positions.

INVESTMENTS & TRADING

SqueezeTrigger -- 28 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts next move in stocks.

GATS -- tracks and quantifies known trading strategies.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. SYNERON MEDICAL LTD (NASDAQ:ELOS) has not approved the statements made in this release. Please read our report and visit our web site, http://www.buyins.net, for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net